SynAct Pharma vinner två priser på GHP 2022

SynAct Pharma utsågs till Best Clinical Biotechnology Company 2022 – Sweden, och Bolagets VD Jeppe Øvlesen vann Biotechnology CEO of the Year 2022 (Sweden) vid Global Health & Pharmas årliga prisutdelning

GHP Magazine has announced the winners of the 2022 Healthcare & Pharmaceutical Awards. (ghp-news.com)